Did Hand-Washing Kill The Flu? | Dr. Ron Paul & Daniel McAdams | RonPaulInstitute.org

Astonishingly, the UK public health authority has announced that this flu season has not seen a single case of influenza. The US and elsewhere are showing similar numbers. Has the flu disappeared? If so, why? The “experts” are claiming that hand-washing, masks, and social distancing have defeated the flu virus. So why didn’t those measures work against the Covid virus? Also today, social media morphs into NATO cheerleaders…

Keep the Ron Paul Liberty Report alive with a tax-deductible contribution to the Ron Paul Institute: http://www.RonPaulInstitute.org/support


Cold Weather❄️, Warm Hearts❤️: Staying Healthy Indoors | Dean & Ayesha Sherzai MDs

Cold Weather, Warm Hearts:
Staying Healthy Indoors

Hi again Sherzai MD Family! 👋

We wanted to start this week by acknowledging that our thoughts are with all of you who are experiencing the horrible ramifications of the winter storms crisscrossing our country right now. We know that the cold temps and snowy days can be rough, especially for your mental health.

We feel you, and we want you to know that you are not alone. Studies show that extreme weather changes can negatively affect mental health for many. One of the most powerful things we can do for ourselves during these times is practice self-care.

This can be as simple as drinking enough water.  Drinking water doesn’t just help you feel good, energized, and healthy but also does wonders for your brain. That’s why we want you to focus on that this week. Read on.

Drink at least 8-10 glasses of water per day! 💧

A properly hydrated brain is an active and healthy brain!

There are so many reasons we need to drink enough water every day. Proper hydration ensures that your brain can receive the nutrients it needs to thrive. Water also helps the brain flush out toxins and dead cells and provides a cushion for your brain to protect it within your skull. The more hydrated you are, the better the padding, the more optimally (and safely) your brain can function! There are additional tangible benefits to hydration, including improved concentration, less irritability and anxiety, and better mood regulation.

Here are some of our tips to stay hydrated:

  1. Make it a game! Every time you check your phone, take a big gulp of water.
  2. Buy a bigger water bottle. One bottle that holds all your necessary water intake for the day helps you track your progress.
  3. Take that bottle with you everywhere! Going from the living room to the kitchen? Don’t forget your trusty hydration companion.
  4. Any time you have a beverage that’s not water (like coffee) pour yourself a glass of water to have alongside it.

We’ve got more tips like these in our upcoming book, The 30-Day Alzheimer’s Solution.

Heart Smart Action Plan Masterclass

When it comes to heart disease, being confident that you’re eating foods that are scientifically proven to improve your heart health today and into the future is becoming increasingly important. And being confident that your nutrition game is on point is 100% essential in today’s world.

Our good friends Cyrus Khambatta, PhD and Robby Barbaro, MPHNew York Times bestselling authors behind the book, Mastering Diabetes, have created a powerful free Masterclass that has helped more than 5,000 people achieve their best heart health in decades. They’ll be teaching this groundbreaking 90-minute live class and you’re invited to join and ask anything that’s on your mind.

(Yes, we know this is not just a reading but instead a whole class. Hear us out though: this is packed full of vital information to help you live a healthier life…and it’s free!)

You’ll discover 5 powerful hacks to lower your blood pressure, triglycerides, and cholesterol by 30 points in 30 days. This Masterclass is action-packed and responsible for helping more than 5,000 people drop their triglycerides, cholesterol, and blood pressure by 30 points. And they do so using food as medicine – not medications!

Sign up here!

Cauliflower Mashed Potatoes.

In the cooler winter months, we love seeking out healthy takes on classic comfort foods. These cauliflower mashed potatoes hit the spot! Plus, they’re packed with the brain health benefits of a crucifer, cauliflower, including antioxidant properties, fiber, and Vitamins C & K. Make a big batch of these at the start of next week and use them as meal prep for the week!

Here’s what you’ll need:

  • 6 Yukon Gold potatoes, peeled and cut into quarters
  • Water to cover
  • ½ head small cauliflower (chopped)
  • 1 cup almond or soy milk
  • 2 to 3 tablespoons plus 1 teaspoon extra-virgin olive oil (EVOO)
  • 3 to 5 cloves of garlic, minced
  • ½ teaspoon salt
  • Black pepper
  • Fresh chives for garnish

For full instructions, read more here.

We’re off to make some brain and heart-healthy comfort food! Water you doing from the list? 😉

Stay warm, family.

Wishing you continued health,

Dean & Ayesha Sherzai


P.S. If you haven’t heard already, our new book, The 30-Day Alzheimer’s Solution, is available for pre-order. Order your copy today!


Source: Cold Weather❄️, Warm Hearts❤️: Staying Healthy Indoors.

Source: Cold Weather❄️, Warm Hearts❤️: Staying Healthy Indoors.

Sorry, but This Gut-Healthy Pumpkin Pie Chia Pudding Is Way Better Than Oatmeal | WellandGood.com

Looking to sneak some vegetables into your breakfast? Check out this video:  pumpkin pie breakfast bowl.

By mid-February you’ve no doubt entered an Oatmeal Slump. You know what I mean: You’ve eaten the go-to warming breakfast grain often enough that you’re on the verge of falling asleep in your bowl. If that resonates, we have a dynamic new comfort meal by way of Adriana Urbina, chef and founder of Tepuy Collective: pumpkin chia pudding. (Oh, and to clarify, that means that the pudding is happily nestled in a pumpkin.)

“You don’t need to take need to take the skin off, because you can eat it, so don’t worry about it, and we’re going to take all the seeds out,” says Urbina. “And also you can save the seeds for another recipe.” Having this base is already a big win for our mornings; packed with potassium plus vitamin A and C, pumpkin is a nutritional powerhouse that should put you in the green with your veggie intake. Gotta love a versatile squash! (And if you can’t find a small pumpkin this time of year, Urbina suggests opting for a kabocha squash instead, which has a similar flavor and texture.)

So what delights do we put in our delicious pumpkin carriage? Well, the pudding itself is a combination of (duh) high-fiber chia seeds, substituting the usual role of our oats. We also have loads of cinnamon, everyone’s favorite warming winter spice, and an excellent way to stabilize your blood sugar levels. Mix in some maple syrup, the nut butter of your choice (Team Almond Butter forevs), and electrolyte-rich coconut milk. Make your pudding 24 hours in advance and pop in the fridge…it should give you enough time to figure out what melange of fruit to add on top. And it’ll feel like a joyful endeavor this time.

Intrigued? Watch the full video to get the recipe, and kiss the Quaker Oats guy buh-bye.

Warm pumpkin pie breakfast bowl


For the chia pudding:
1/4 cup chia seeds
1 cup coconut milk or plant milk
1 1/2 tsp pumpkin pie spice
1 tsp pure vanilla extract
2 Tbsp maple syrup
Pinch of salt

For the squash bowls:
2 small acorn squash or pumpkin
1/3 cup maple syrup
2 Tbsp cinnamon
1/4 cup nut butter

For topping (optional):
1 tsp cinnamon
2 Tbsp maple syrup
Nut butter
Sliced banana
Pumpkin seeds
Dried cranberries

1. First, make your chia pudding: Combine all chia pudding ingredients together and stir for a few minutes until it starts to thicken. Pour into a covered glass container and chill overnight.

2. Preheat the oven to 450 degrees. Slice the squash in half and scoop out the seeds. Place the squash on a parchment-lined baking sheet flesh side up.

3. Combine nut butter, maple syrup, and cinnamon in a glass, and divide mixture between squash halves. Rub it into the sides and on the top using your fingers.

4. Roast the squash in the oven for 25 minutes until it starts to turn brown. While it bakes, assemble your toppings (if using).

5. Remove squash from the oven and let cool slightly for about 5 minutes. Fill the centers of the squash with chia pudding, your desired toppings, then finish with a drizzle of honey and sprinkled cinnamon.

Oh hi! You look like someone who loves free workouts, discounts for cult-fave wellness brands, and exclusive Well+Good content. Sign up for Well+, our online community of wellness insiders, and unlock your rewards instantly.

Source: Sorry, but This Gut-Healthy Pumpkin Pie Chia Pudding Is Way Better Than Oatmeal

Nutrition and COVID-19 | Dr. Pam Popper | MakeAmericansFreeAgain.com


Unfortunately, YouTube has censored us from uploading any videos for a week so we cannot post our Video Clip.

You can see today’s video clip here on BitChute https://www.bitchute.com/video/rtukYO8mLVOj/

Give us a call at 614-841-7700.

You can subscribe to Pam’s BitChute channel here – https://www.bitchute.com/channel/PBxgBgr9rAE6/

Check out https://makeamericansfreeagain.com/

Source: Nutrition and COVID-19

Does Heme Iron Cause Cancer? Michael Greger M.D. FACLM February 17, 2021 | NutritionFacts.org

Laboratory models suggest that extreme doses of heme iron may be detrimental, but what about the effects of nutritional doses in humans? A look at heme’s carcinogenic effects.

Doctor’s Note

This is part of a nine-video series on plant-based meats. If you missed any of the other earlier installments, check out:

The final two videos in the series are coming up next. See:

If you want all of nine of the videos on this plant-based meat series in one place, you can get them right now in a digital download from my webinar a few months ago.

If you haven’t yet, you can subscribe to my videos for free by clicking here.


The Real Truth About Health Conference, Melville, NY – Wow! Look what’s coming up. Check this out!

The Real Truth About Health is having the world’s largest free live health and environmental conference being held in Melville, NY. April 23-May 2, 2021

Source: The Real Truth About Health Conference, Melville, NY

The Way Your Body Is Physically Structured Determines What You’re Supposed To Eat – By Milton Mills, MD | The Real Truth About Health

Milton Mills, MD practices urgent care medicine in the Washington DC area, and has served previously as Associate Director of Preventive Medicine and as a member of the National Advisory Board, for Physicians Committee for Responsible Medicine (PCRM). He has been a major contributor to position papers presented by PCRM to the United States Department of Agriculture regarding Dietary Guidelines for Americans, and has been the lead plaintiff in PCRM’s class action lawsuit that asks for warning labels on milk. Dr. Mills earned his medical degree at Stanford University School of Medicine, and completed an Internal Medicine residency at Georgetown University Hospital. He has published several research journal articles dealing with racial bias in federal nutrition policy. He frequently donates his time via practicing at free medical clinics, and travels widely, speaking at hospitals, churches and community centers throughout the country. He was featured in the recent attention-getting film “What the Health,” and will also appear in the upcoming film “The Silent Vegan.”

Connect with The Real Truth About Health: http://www.therealtruthabouthealth.com/

https://www.facebook.com/The-Real-Tru… https://www.instagram.com/therealtrut…



Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO’s. Fighting to stop climate change and extinction.

Please support the sponsors of our conference http://www.therealtruthabouthealthcon…

Bill Gates: Third Shot May Be Needed to Combat Coronavirus Variants • Children’s Health Defense | Megan Redshaw, M.D. | The Defender  | childrenshealthdefense.org

Gates told CBS News we might need a third shot of a currently available vaccine, or a “modified” vaccine as the virus mutates, but CHD’s RFK, Jr. asks why we haven’t focused instead on non-vaccine strategies, including therapeutic drugs.

With more than 40 million Americans having received at least the first dose of the Pfizer or Moderna vaccine, a third dose may be needed to prevent the spread of new variants of the disease, Bill Gates told CBS News Tuesday.

Gates’ comments come amid growing concern that the current vaccines are not effective against the more contagious Brazilian and South African variants.

Pfizer and Moderna have stated that their vaccines are 95% and 99% effective, respectively, against the initial strain of COVID. However, some scientists have questioned those statements. Additionally, the World Health Organization and vaccine companies have conceded that the vaccines do not prevent people from being infected with COVID or from transmitting it, but are only effective at reducing symptoms.

Gates told CBS Evening News:

“The discussion now is do we just need to get a super high coverage of the current vaccine, or do we need a third dose that’s just the same, or do we need a modified vaccine?”

U.S. vaccine companies are looking at making modifications, which Gates refers to as “tuning.”

People who have had two shots may need to get a third shot and people who have not yet been vaccinated would need the modified vaccine, explained Gates. When asked whether the coronavirus vaccine would be similar to the flu vaccine, which requires yearly boosters, Gates couldn’t rule that out. Until the virus is eradicated from all humans, Gates said, additional shots may be needed in the future.

AstraZeneca in particular has a challenge with the variant,” Gates explained. “And the other two, Johnson & Johnson and Novavax, are slightly less effective, but still effective enough that we absolutely should get them out as fast as we can while we study this idea of tuning the vaccine.”

The Bill & Melinda Gates Foundation is funding the studies being conducted in Brazil and South Africa, CBS News said. The foundation has also invested in the AstraZeneca, Johnson & Johnson and the Novavax vaccines, which are being tested against new variants. Once the AstraZeneca vaccine is approved, the Global Alliance for Vaccine Initiative or GAVI, founded by Gates, will distribute it globally.

“Gates continues to move the goalposts,” said Robert F. Kennedy, Jr., chairman and chief legal counsel of Children’s Health Defense. “Meanwhile the strategies he and others have promoted are obliterating the global economy, demolishing the middle class, making the rich richer and censoring vaccine safety advocates, like me.”

Kennedy said that the exclusive focus on vaccines has prevented the kind of progress required to actually address and recover from the pandemic:

Continue reading on Source …

Source: Bill Gates: Third Shot May Be Needed to Combat Coronavirus Variants • Children’s Health Defense

Breaking Up is Hard to Do: Lessons Learned from a Pharma-Free Practice Transformation | JABFM.ORG

The Journal of the American Board of Family     Medicine: 26 (3)

David Evans, Daniel M. Hartung, Denise Beasley and Lyle J. Fagnan


Background: Academic medical centers are examining relationships with the pharmaceutical industry and making changes to limit interactions. Most doctors, however, practice outside of academic institutions and see pharmaceutical detailers and accept drug samples and gifts. Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs.

Methods: A small private practice, setting out to transform into a pharma-free clinic, used a practice transformation process that examined the industry presence in the clinic, educated the doctors on potential conflicts of interest, and improved practice flow. Staff were given the opportunity to share concerns, and their issues were acknowledged. Educational interventions were developed to help providers keep current. Finally, efforts were made to educate patients about the policy.

Results: The clinic recorded the degree to which it was detailed. Loss of gifts, keeping current with new drugs, and managing without samples were noted concerns. Policy change champions developed strategies to address concerns.

Discussion: A shift in practice culture to a pharma-free clinic is achievable and maintainable over time. Barriers to success can be identified and overcome with attention given to careful gathering of information, staff input, and stakeholder education.

The precarious relationship between the pharmaceutical industry and the individual physician was first described by Charles May in 1961 in a paper entitled “Selling Drugs by ‘Educating’ Physicians.”1 After more than 50 years and the accumulation of extensive literature on the subject, much of the responsibility still remains with the individual practitioner to ensure he or she is not subject to undue industry influence.

The pharmaceutical industry spends between $12 and $57 billion per year on promotional activities.2,3 A majority of this money goes to the provision of drug samples and face-to-face product detailing by pharmaceutical representatives to physicians. Although many companies have scaled back their sales force, as of 2009 pharmaceutical companies employed a sales force of 92,000, or 1 drug representative for every 8 physicians.457

The powerful influence of pharmaceutical marketing on the prescribing patterns of physicians has been documented and has led to calls for reform at the institutional, professional, and individual levels to minimize this impact.6,812 In the past decade several states and many major academic medical centers have enacted policies that either restrict or mandate disclosure of financial relationships with industry.13,14 Most notably, the Affordable Care Act of 2010 contains the Physician Payment Sunshine Act, which requires manufacturers of drugs, devices, and biologics paid for by Medicare or Medicaid to report all payments to physicians and teaching hospitals to a publically accessible database starting August 2013.15 Others have proposed more stringent guidelines for managing clinician-industry interactions and substantial federal investment in research to promote noncommercial, evidence-based practices.16 Where does that leave the long-established relationship between pharmaceutical representatives and practicing physicians? While significant progress at the state, federal, and institutional levels has been made to curb these problematic relationships, little guidance exists for physicians and other clinicians in small, independent practices.17

Against this historical and cultural backdrop, a small, private, family medicine clinic examined the degree to which pharmaceutical representatives detailed and provided samples to the practice. After this internal audit and self-study, the practice partners decided by consensus to pursue a policy prohibiting pharmaceutical industry interactions, including accepting and distributing drug samples. Despite the consistent evidence suggesting a negative effect of the physician-pharmaceutical relationship,6,8,12 little guidance on how to transform a practice from being heavily detailed to pharma-free exists for those contemplating a policy change. Accounts of how various practices handle their drug sample inventories have been described,1820 but the literature is relatively silent on the steps practices can take to extricate themselves completely from interactions with the pharmaceutical industry. The objective of this article is to describe the efforts of this small private practice of 5 physicians and a physician assistant as it embarked on an intentional and carefully considered path to discontinue seeing pharmaceutical representatives and to stop accepting and distributing drug samples.


Madras Medical Group is a privately owned family medicine practice located in rural Oregon. There are 5 family physicians and a PA-C who provide the full spectrum of family medicine services, including obstetrics. The clinic also employs 18 supporting staff. Madras Medical Group is the largest medical provider in a catchment area serving 20,000 people.

To better understand the nature of the interactions between the clinic and pharmaceutical representatives, objective data were collected documenting the nature and magnitude of industry connections. First, from March to August 2005, the practice recorded the number of visits to the practice by pharmaceutical detailers and the number of lunches provided. In this clinic, pharmaceutical representatives did not detail on a scheduled basis but visited the clinic on a drop-in basis only. The record keeping was done by the office manager as part of a routine practice of noting all visits from nonpatient clinic visitors (eg, drug representatives, repair persons, delivery persons). The office manager was not aware that the record of pharmaceutical representative visits or lunches was to be used as part of this evaluation.

In addition, accepted drug samples were recorded. To estimate the value of the samples, historical average wholesale price data were obtained and the monthly cost was determined based on Oregon Medicaid reimbursement rates. For comparative purposes a potential generic or lower-cost alternative for each sample medicine was identified, and the monthly cost of that was estimated in a similar manner.

Finally, three physician partners (including one of the authors, DE) held group and individual interviews with both clinical and front office staff to identify their concerns about a potential change in practice culture as well as share the data collected about the frequency of industry detailing and drug samples. Madras Medical Group has a history of conducting informal interviews with clinic staff regularly to evaluate attitudes about clinic operations and policies for quality improvement purposes. For this project, interviews were conducted between September 1 and December 1, 2005. Questions asked of clinicians and nonclinical staff centered around the value of drug detailer visits to patients and the clinic, perceived staff benefits of visits to the staff, and losses if the clinic became pharma-free. Providers also were asked to evaluate qualitatively the usefulness of sampled medicines. Responses to interviews were summarized by interviewers and presented to the provider group to identify common themes and concerns from providers and staff. In particular, the provider group sought to understand the relative value and risks of continued interactions with industry representatives. Results of this process were used to inform the proposed policy restricting drug detailing and samples that was implemented January 1, 2006.

Because this work was conducted as part of routine clinic quality improvement, informed consent was not obtained. Subsequent evaluation of this policy and these data were approved by the Oregon Health & Science University Institutional Review Board (IRB-4596


During the 6 months immediately preceding the decision to change the pharmaceutical detailer policy, the practice was visited 199 times (an average of 33.17 times per month; minimum, 29 times; maximum, 37 times) by pharmaceutical representatives. Drug companies sponsored 23 in-clinic lunches from February to November, an average of 2.3 lunches per month.

Inventory of the sample cabinet showed very few first-line drugs available for the most common illnesses seen in the practice. The inventory of sampled medicines along with reasonable first-line alternatives is shown in Table 1. The estimated average price per month of the sampled medicines was $90. Reasonable less expensive alternatives could be identified for 38 of 46 sampled drugs. At an average of $22 per month, using a less expensive, often generic alternative would save the ultimate payer $70 per therapy per month.

Table 1. Inventory of Sampled Medicines, Potential Alternative Drugs, and Estimated Monthly Costs

During the individual and group interviews, four themes emerged. The physicians were concerned about (1) the practice culture of seeing detailers, (2) the effect they had on staff morale, (3) sample expectations of patients and physicians, and (4) being current on new drugs. Efforts were made to mitigate these issues. Not all providers in the practice initially were willing to discontinue seeing drug detailers and accepting samples. There were two provider champions of the proposed policy, two who leaned toward making the change, and two who did not want to change the policy. Small interim steps were taken while the practice engaged in clinician education. These steps included limiting lunches to once per month. Detailers were asked to only present peer-reviewed materials during visits.

Interviews with staff identified several other concerns. First, staff enjoyed the promotional items that are distributed frequently by drug representatives, such as pads of paper, pens, and mugs. Many of the branded items were taken home by staff members. Second, physicians, staff and their family members personally used samples in the cabinets. Most important, staff enjoyed the opportunity to get together socially for lunch when it was provided for them.

The clinic proactively made several steps to alleviate staff and physician concerns about the policy change. First, provider champions began a process to educate both themselves and other clinicians on the literature related to the ethics of the physician-industry relationship and its effect on practice. During monthly morning clinic meetings, peer-reviewed literature was presented regarding the influence of pharmaceutical detailing and drug samples on prescribing patterns, prescribing safety, increased drug costs, and the ethics of gifting. The Truth About the Drug Companies by Marcia Angell21 was read and discussed. The fallout from the effects of rofecoxib on cardiac health and the subsequent congressional investigation was researched and discussed actively among the physicians. These efforts resulted in the consensus adoption and implementation of a pharma-free policy, which went into effect on January 1, 2006.

The practice implemented a monthly all-clinic lunch with protected time for staff. The cost of this lunch ranges from $60 to $80. While the providers acknowledged that the staff enjoyed gifts and the use of samples, no efforts were made to replace these. Branded office supplies that were found in the clinic were disposed of and replaced with supplies purchased at local businesses, when possible, at a cost of less than $200. Nonindustry drug information sources were identified, and a monthly educational provider meeting was established to discuss both new and old drugs. Patient educational materials describing the transition were developed and distributed. Finally, the local press was notified of the policy change. A press release describing the policy change and the reasons behind it was issued. Two articles were published in the local and regional newspapers.


Considerable progress has been made over the past several years in describing the physician-pharmaceutical relationship, its effects on care, the veracity of information distributed, and qualifying its effect on prescribing.8,12 A large amount of literature suggests that interaction with industry is associated with substantial negative consequences on patient safety, cost of drugs to patients, generic prescriptions, and evidence-based prescribing.12 Although physician interactions with industry have declined in recent years—likely because of increased scrutiny and regulation—the proportion of primary care physicians with industry relationships remains stubbornly high (84%).22 To date, practice transformation related to industry conflicts of interest has been dictated to clinicians largely through administrative changes at large academic medical centers and large health systems.9 In 2008, the Association of American Medical Colleges published recommendations to assist medical centers in developing policy to minimize undue industry conflicts of interest and encourage high standards of medical professionalism.23 However, of the approximately 800,000 doctors in the United States, only 22% practice in academic settings. To our knowledge this is the first report documenting a process that small private practices can consider when contemplating restrictions in how they interact with the pharmaceutical industry. This description of an internal practice change contributes to the ongoing discussion of the potential clinical influence and the ethics of the relationship between practicing physicians and pharmaceutical marketing.

Quantifying the Clinic-Industry Relationship

A key aspect of the success of this policy change was the preliminary work of evaluating exactly how often and in what manner the clinic was visited by drug detailers. The clinic was visited, on average, 33 times per month, or approximately 6 times per clinician per month, which is consistent with published national representative 2004 estimates (median visits, 8).22 Furthermore, qualitative and quantitative analyses of the samples available played an important role. Providers were able to see that most sampled medicines were brand drugs for which less expensive options often were available. This foundation of information allowed the champions of the policy to rationally discuss changes with the other providers. This data also allowed the clinic providers to put the results of the discussed peer-reviewed literature into the context of their everyday clinical experience.

Anticipating Clinician and Staff Concerns

Continue reading online where a PDF is also available: https://www.jabfm.org/content/26/3/332